The practical management of the gastrointestinal symptoms of pelvic radiation disease
Misc authors, July 2014
A new report from Jervoise Andreyev and his team at the Marsden was published as an open access article in Frontline Gastroenterology and can be found via the following link:
Macmillan funded the design and print of a formatted version to be used in practice by professionals and an online version of that can be found here: www.macmillan.org.uk/prdgastroguidance.
Macmillan are now starting to draft a 'quick guide' version of this report for use in primary care. This document will provide GPs with information about how to identify patients with chronic GI effects of cancer treatment and what tests and interventions they can do, and finally guidance on when a referral needs to be made to a specialist.
Pancreatic Section Survey
Survey of UK pathologists' approach to pancreatectomies for ampullary / pancreatic / bile duct cancer
R Feakins, F Campbell and C Verbeke
for the Audit committee and the Pathology section of the British Society of Gastroenterology (BSG)
Presented at the BSG Pathology section meeting, March 2009
Download survey results [ 330 Kb ]
Co-owned BSG Journal Gut improves its impact factor again
The BSG is pleased to update members that 2015 journal Impact Factors have just been released and Gut's has increased from 14.660 to 14.921. This is the fourth consecutive increase in these figures and is testament to the work of the excellent Editorial team.
Gut retains second place in the world rankings behind Gastroenterology (18.187) and just ahead of Nature Reviews Gastroenterology & Hepatology (14.435). Hepatology was 4th at 11.711 and J Hepatology dropped to 5th at 10.590. Am J Gastroenterology dropped a little to 10.383 and CGH also dropped a little to 7.680. In total, there were 6 GI/Liver journals with Impact Factors above 10 out of a total of 78 GI journals at present, demonstrating the strength of the specialty.
Professor Emad El-Omar, Editor in Chief of Gut said:
"I am very pleased with our progress as a journal; we continue to break new records and I am delighted that we have improved our position within the rankings for gastroenterology/hepatology and have now moved up from 97th to 88th of all 12,000 journals listed in the JCR rankings."
"Our achievements and success are a testament to the hard work and dedication of the Editorial and wider journal team over the past six years."
"I would like to take this opportunity to congratulate the team on the success and to express my everlasting gratitude."
Commenting on the figures, BSG President Dr Ian Forgacs said:
"To have increased the Impact Factor of Gut in every year since 2011 is a phenomenal achievement and reflects the collective and total commitment of the whole editorial team to the journal which has involved an incredible amount of hard work in an increasingly competitive environment. It must be wonderfully satisfying for them to see this endeavour recognised."
"The very high global stature that Gut has achieved is the result of a great international collaboration of which every gastroenterologist and liver doctor in the UK should be very proud."
Using the Clinical Research Network
The NIHR Clinical Research Network (NIHR-CRN)
How to use it to do clinical research
Most Gastroenterologists want to participate in Clinical Research but don’t know how to and/or haven’t got the support.
Not any more!
- Using the CCRN - A Guide[ 230 Kb ]
The Gastroenterology and Hepatology Specialty Groups are two of 30 Specialty Groups which provide national networks of topic-specific expertise. These groups are key to the success of the CRN. They work at both national and local levels to ensure the successful delivery of research within their specialties. This means ensuring that studies are delivered to target and on time. Further information on their remits and portfolio of trials can be found here:
Further information is available in the article published in January 2012 in Frontline Gastroenterology. In order to view the article, BSG members will need to log-in.
Alcohol Related Disease (2010)
Alcohol Related Disease: Meeting the Challenge of Improved Quality of care and Better Use of Resources
A Joint Position Paper by BSG/BASL/AHA
Alcohol misuse and alcohol-related problems, especially binge drinking and alcohol-related liver disease, are major public health concerns. Recently, much attention has focused on social policy and measures to reduce drinking. There is an additional need to provide care for a large and growing group of patients with alcohol-related problems, where national quality standards are lacking and the absence of coordinated policies means care is imperfect and spending is poorly targeted and ineffective.
- Download document [ 4.7 Mb ]
Addendum: 9th November 2010
BSG/Alcohol Health Alliance urge SHAs to invest in alcohol services to reduce hospital readmissions
A recent letter from David Florey CBE, NHS Deputy Chief Executive, has urged PCTs and SHAs to develop these plans to ensure that patients who are discharged from hospital receive ongoing and seamless care that will reduce avoidable hospital readmissions. £70 million has been made available to do this. The BSG and Alcohol Health Alliance have written to SHAs to encourage them to invest in alcohol services. The following links will take you to the letter and briefing document, which may be useful to you in encouraging investment locally.
- Treatment of Alcohol- Related Disease: the compelling case for post-discharge support [ 1.3 Mb ]
- Letter Template [ 286 kb ]
Page 1 of 17